Back
Day Range
$13.48
$14.13
52-Week Range
$10.28
$28.40
Volume
1,133,413
50D / 200D Avg
$13.81
/
$18.38
Prev Close
$13.51
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -64.1 | 14.0 |
| P/B | 3.6 | 2.4 |
| ROE % | -8.7 | 11.4 |
| Net Margin % | -4.9 | 10.1 |
| Rev Growth 5Y % | — | 7.0 |
| D/E | 0.0 | 0.5 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Generating 16.93M in free cash flow
PEG of 0.97 suggests growth is underpriced
Capital efficient — spends only 0.51% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)53.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-8.68%
ROIC-3.91%
Net Margin-4.91%
Op. Margin-4.60%
Safety
Debt / Equity
0.00
Current Ratio3.60
Interest Coverage-4.72
Valuation
P/E Ratio
-64.10
P/B Ratio3.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53.24% | Revenue Growth (3Y) | 45.58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 260.21M | Net Income (TTM) | -12.78M |
| ROE | -8.68% | ROA | -4.18% |
| Gross Margin | 65.52% | Operating Margin | -4.60% |
| Net Margin | -4.91% | Free Cash Flow (TTM) | 16.93M |
| ROIC | -3.91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 3.60 |
| Interest Coverage | -4.72 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -64.10 | P/B Ratio | 3.57 |
| P/S Ratio | 3.15 | PEG Ratio | 0.97 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 819.06M | Enterprise Value | 597.03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 260.21M | 169.80M | 122.78M | 89.19M |
| Net Income | -12.78M | -47.14M | -67.51M | -72.52M |
| EPS (Diluted) | -0.22 | -0.85 | -1.21 | -1.30 |
| Gross Profit | 170.50M | 102.88M | 69.97M | 42.79M |
| Operating Income | -11.97M | -43.65M | -66.00M | -72.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 305.41M | 150.89M | 175.08M | 221.80M |
| Total Liabilities | 75.73M | 86.26M | 76.16M | 66.19M |
| Shareholders' Equity | 229.68M | 64.63M | 98.92M | 155.61M |
| Total Debt | 0.0 | 30.19M | 30.58M | 30.81M |
| Cash & Equivalents | 222.04M | 76.39M | 115.64M | 168.12M |
| Current Assets | 272.93M | 113.06M | 142.88M | 188.56M |
| Current Liabilities | 75.73M | 53.95M | 43.79M | 34.51M |